期刊
TRENDS IN BIOCHEMICAL SCIENCES
卷 35, 期 8, 页码 442-449出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibs.2010.03.004
关键词
-
资金
- NCI NIH HHS [R01 CA058836, R01 CA058836-15] Funding Source: Medline
PTP1B, a non-transmembrane protein tyrosine phosphatase that has long been studied as a negative regulator of insulin and leptin signaling, has received renewed attention as an unexpected positive factor in tumorigenesis. Here, we highlight how views of this enzyme have evolved from regarding it as a simple metabolic off-switch to a more complex view of PTP1B as an enzyme that can play both negative and positive roles in diverse signaling pathways. These dual characteristics make PTP1B a particularly attractive therapeutic target for diabetes, obesity, and perhaps breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据